Morris M, Woods L M, Bhaskaran K, Rachet B
Faculty of Epidemiology and Population Health, Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel St, London, WC1E 7HT, UK.
BMC Cancer. 2017 Feb 23;17(1):155. doi: 10.1186/s12885-017-3129-4.
In England and Wales breast cancer survival is higher among more affluent women. Our aim was to investigate the potential of pre-diagnostic factors for explaining deprivation-related differences in survival.
Individually-linked data from women aged 50-70 in the West Midlands region of England, diagnosed with breast cancer 1989-2006 and continuously eligible for screening, was retrieved from the cancer registry, screening service and Clinical Practice Research Datalink. Follow-up was to the end of July 2012. Deprivation was measured at small area level, based on the quintiles of the income domain of the English indices of deprivation. Consultation rates per woman per week, time from last breast-related GP consultation to diagnosis, and from diagnosis to first surgery were calculated. We estimated net survival using the non-parametric Pohar-Perme estimator.
The rate of primary care consultations was similar during the 18 months prior to diagnosis in each deprivation group for breast and non-breast symptoms. Survival was lower for more deprived women from 4 years after diagnosis. Lower net survival was associated with more advanced extent of disease and being non-screen-detected. There was a persistent trend of lower net survival for more deprived women, irrespective of the woman's obesity, alcohol, smoking or comorbidity status. There was no significant variation in time from last breast symptom to diagnosis by deprivation. However, women in more deprived categories experienced significantly longer periods between cancer diagnosis and first surgery (mean = 21.5 vs. 28.4 days, p = 0.03). Those whose surgery occurred more than 12 weeks following their cancer diagnosis had substantially lower net survival.
Our data suggest that although more deprived women with breast cancer display lifestyle factors associated with poorer outcomes, their consultation frequency, comorbidities and the breast cancer symptoms they present with are similar. We found weak evidence of extended times to surgical treatment among most deprived women who were not screen-detected but who presented with symptoms in primary care, which suggests that treatment delay may play a role. Further investigation of interrelationships between these variables within a larger dataset is warranted.
在英格兰和威尔士,较为富裕的女性乳腺癌生存率更高。我们的目的是研究诊断前因素解释与贫困相关的生存差异的可能性。
从癌症登记处、筛查服务机构和临床实践研究数据链中检索了1989年至2006年在英格兰西米德兰兹地区被诊断为乳腺癌且持续符合筛查条件的50至70岁女性的个体关联数据。随访至2012年7月底。基于英国贫困指数收入领域的五分位数,在小区域层面测量贫困程度。计算每位女性每周的就诊率、从上次与乳房相关的全科医生就诊到诊断的时间,以及从诊断到首次手术的时间。我们使用非参数Pohar-Perme估计器估计净生存率。
在每个贫困组中,乳腺癌和非乳腺癌症状诊断前18个月的初级保健就诊率相似。诊断后4年,贫困程度更高的女性生存率较低。较低的净生存率与疾病进展程度更高以及未通过筛查发现有关。无论女性的肥胖、饮酒、吸烟或合并症状况如何,贫困程度更高的女性净生存率持续较低。按贫困程度划分,从最后出现乳房症状到诊断的时间没有显著差异。然而,贫困程度较高类别的女性在癌症诊断和首次手术之间的时间明显更长(平均分别为21.5天和28.4天,p = 0.03)。那些在癌症诊断后超过12周才进行手术的患者净生存率大幅降低。
我们的数据表明,尽管贫困程度更高的乳腺癌女性表现出与较差预后相关的生活方式因素,但她们的就诊频率、合并症以及所呈现的乳腺癌症状相似。我们发现,在未通过筛查发现但在初级保健中出现症状的最贫困女性中,手术治疗时间延长的证据较弱,这表明治疗延迟可能起了作用。有必要在更大的数据集中进一步研究这些变量之间的相互关系。